Magnesium oxide

Overview

Magnesium oxide is an inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.

Indication

Indicated for over-the-counter use as a supplement for cardiovascular and neuromuscular health, and as an antacid for relief of acid indigestion and upset stomach. Magnesium oxide, in combination with sodium picosulfate and anhydrous citric acid, is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients ages 9 years and older.

Associated Conditions

Dyspepsia
Heartburn

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients	2025/04/30	NCT06950138	Phase 3	Completed	Coordinación de Investigación en Salud, Mexico
The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients	2019/02/15	NCT03840226	Phase 3	Recruiting	Sheba Medical Center
A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents	2018/03/23	NCT03475693	Early Phase 1	Completed	Spectrum Health - Lakeland
Effect of Magnesium Supplement in Early Pregnancy After ICSI	2018/01/12	NCT03398031	Phase 3	UNKNOWN	Ain Shams University
Acetylsalicylic Acid and Type 2 Diabetes Mellitus	2017/11/14	NCT03341117	Phase 3	Completed	Centro Universitario de Ciencias de la Salud, Mexico
Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic Patients	2017/10/18	NCT03313856	Phase 2	Completed	Centro Universitario de Ciencias de la Salud, Mexico
The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation	2017/02/16	NCT03054805	Phase 4	Completed	Chang Gung Memorial Hospital
Capsaicin Effect on Cytokines Profile in Dyslipidemia	2016/07/06	NCT02823912	Phase 2	UNKNOWN	University of Guadalajara
Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy	2014/05/02	NCT02129231	Phase 2	Completed	University of Guadalajara
Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)	2012/02/03	NCT01525875	Phase 2	Completed	Mark Lebwohl

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Quflora Pediatric	CarWin Pharmaceutical Associates, LLC	15370-105	ORAL	15 mg in 1 1	1/10/2024
Vitafol Fe Plus	Exeltis USA, Inc.	0642-7473	ORAL	20 mg in 1 1	2/14/2023
BACMIN	Marnel Pharmaceuticals, Inc.	0682-3001	ORAL	50 mg in 1 1	5/2/2014
Vitramyn	PureTek Corporation	59088-193	ORAL	200 mg in 1 1	1/11/2023
Prenate Essential	Avion Pharmaceuticals, LLC	75854-313	ORAL	50 mg in 1 1	1/7/2021
PRENATE DHA	Avion Pharmaceuticals, LLC	75854-312	ORAL	50 mg in 1 1	1/7/2021
Keylosa	Novian Pharmaceuticals	83146-003	ORAL	200 mg in 1 1	10/6/2023
Quflora Pediatric	CarWin Pharmaceutical Associates, LLC	15370-104	ORAL	15 mg in 1 1	1/10/2024
PRENATE Enhance	Avion Pharmaceuticals, LLC	75854-309	ORAL	50 mg in 1 1	1/7/2021
Quflora Pediatric Drops	CarWin Pharmaceutical Associates, LLC	15370-101	ORAL	12 mg in 1 mL	8/3/2017

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
PICOPREP Powder for Oral Solution	Ferring Pharmaceuticals (China) Co., Ltd.	SIN14303P	POWDER, FOR SOLUTION	3.5 g	1/30/2013
GERSKIN TABLET	Y S P INDUSTRIES (M) SDN BHD	SIN07893P	TABLET	200 mg	10/31/1994
PICO-SWIFT POWDER FOR ORAL SOLUTION	IND-SWIFT LIMITED	SIN17163P	POWDER, FOR SOLUTION	3500mg	1/16/2025

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
IsaFlush	195819	Isagenix Asia Pacific Australia Pty Ltd	Medicine	A	3/17/2012
Top Life Cellenova	330661	Homart Pharmaceuticals Pty Ltd	Medicine	A	3/3/2020
Honey Spring NAD+Se	367059	Vastrade Meditek Pty Ltd	Medicine	A	5/25/2021
My Vit Women’s Breastfeeding and Pregnancy	349252	Bridge Brands Pty Ltd	Medicine	A	11/23/2020
Honey Spring NAD+Men	351666	Vastrade Meditek Pty Ltd	Medicine	A	12/14/2020
TURMERIC PLUS MAGNESIUM	355278	RF Six Pty Ltd	Medicine	A	2/19/2021
Performance Plus Apple+Berry	450567	Procter & Gamble Australia Pty Ltd	Medicine	A	6/3/2024
Caltrate Bone & Muscle	214783	Haleon Australia Pty Ltd	Medicine	A	9/19/2013
Swisse Ultivite Multivitamin with Ginkgo Extract + Taurine	394150	Swisse Wellness Pty Ltd	Medicine	A	8/19/2022
NUTRIWAY DOUBLE X - MINERAL SUPPLEMENT.	289111	Amway of Australia	Medicine	A	5/18/2017

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
C-APNTO-B6 VITAMINS W MAGNESIUM TAB	METAGENICS, INC.	00748218	Tablet - Oral	60 MG / TAB	12/31/1989
ASPIRIN PLUS STOMACH GUARD TAB	sterling winthrop inc.	02078449	Tablet - Oral	63 MG / TAB	12/31/1994
MAGNESIUM COMPRIME TAB	herbes universelles inc.	00819603	Tablet - Oral	136 MG	12/31/1990
ORAL PURGATIVE	odan laboratories ltd	02370271	Powder For Solution - Oral	3.5 G / PCK	11/16/2011
MAGNESIA USTA-INJEEL FORTE LIQ	Biologische Heilmittel Heel Gmbh	02064618	Liquid - Oral	6 D / 1.1 ML	12/31/1994
HEPABYL	santé naturelle (ag) ltée	00559857	Tablet - Oral	50 MG	12/31/1983
MAGNESIUM CAP	alsi cie ltee	00587389	Capsule - Oral	82 MG / CAP	12/31/1983
CITRACLEEN	laboratorios casen-fleet, s.l.u.	02437880	Powder For Solution - Oral	3.5 G / 15.08 G	N/A
KIDMAG VITAMINS W MAGNESIUM TAB	METAGENICS, INC.	00748242	Tablet - Oral	100 MG / TAB	12/31/1989
PURG-ODAN	odan laboratories ltd	02317966	Powder For Solution - Oral	3.5 G / SACHET	2/16/2009

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access